Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment

Cancer Letters

Volumn 339, Issue 1, 2013, Pages 70-81

  Song, Yu jiao ^a   Zhang, Shan shan ^a   Guo, Xian ling ^a   Sun, Kai ^a   Han, Zhi peng ^a   Li, Rong ^a   Zhao, Qiu dong ^a   Deng, Wei jie ^a   Xie, Xu qin ^a   zhang, Jian wei ^a   Wu, Meng chao ^a   Wei, Li xin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; CD133; Hypoxia and nutrient starvation (H S); Liver cancer stem cells (LCSCs); Tumor microenvironment

Indexed keywords

CD133 ANTIGEN; CHLOROQUINE; GREEN FLUORESCENT PROTEIN; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER PROGNOSIS; CANCER STEM CELL; CELL HYPOXIA; CELL SURVIVAL; CLONOGENESIS; DRUG EFFICACY; ELECTRON MICROSCOPY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; LIVER CANCER; MALE; MOUSE; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; STARVATION; TREATMENT RESPONSE; TUMOR MICROENVIRONMENT;

4′,6′-DIAMIDINO-2-PHENYLINDOLE; ATG; AUTOPHAGY; AUTOPHAGY-RELATED GENE; CCK8; CD133; CELL COUNTING KIT-8; CHLOROQUINE; CQ; DAPI; FITC; FLUORESCEIN ISOTHIOCYANNATE; GFP-LC3; GREEN FLUORESCENT PROTEIN-LINKED LC3; H/S; HCC; HEPATOCELLULAR CARCINOMA; HYPOXIA AND NUTRIENT STARVATION; HYPOXIA AND NUTRIENT STARVATION (H/S); LC3; LCSCS; LIVER CANCER STEM CELLS; LIVER CANCER STEM CELLS (LCSCS); MICROTUBULE-ASSOCIATED PROTEIN1 LIGHT CHAIN 3; PI; PROPIDIUM IODIDE; TEM; TRANSMISSION ELECTRON MICROSCOPE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIGENS, CD; AUTOPHAGY; CELL HYPOXIA; CELL LINE, TUMOR; CELL SURVIVAL; CHLOROQUINE; GLYCOPROTEINS; HUMANS; LIVER NEOPLASMS; MALE; MICE; NEOPLASTIC STEM CELLS; PEPTIDES; STARVATION; TRANSPLANTATION, HETEROLOGOUS; TUMOR MICROENVIRONMENT; TUMOR STEM CELL ASSAY;

EID: 84883445521     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.07.021     Document Type: Article

References (39)

1. Block T.M., Mehta A.S., Fimmel C.J., Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003, 22:5093-5107.
2. Ma S., Chan K.W., Hu L., Lee T.K., Wo J.Y., Ng I.O., Zheng B.J., Guan X.Y. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556.
3. Lobo N.A., Shimono Y., Qian D., Clarke M.F. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 2007, 23:675-699.
4. Ma S., Lee T.K., Zheng B.J., Chan K.W., Guan X.Y. CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 2008, 27:1749-1758.
5. Zhao Wei, Wang Limin, Han Haibo, Jin Kemin, Lin Na, Guo Ting, Chen Yangde, Cheng Heping, Lu Fengmin, Fang Weigang, Wang Yu, Xing Baocai, Zhang Zhiqian 1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-Initiating cells by binding to the calcium channel α2δ1 subunit. Cancer Cell 2013, 23:541-556.
6. Chiba T., Kita K., Zheng Y.-W., Yokosuka O., Saisho H., Iwama A., Nakauchi H., Taniguchi H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006, 44:240-251.
7. Song W., Li H., Tao K., Li R., Song Z., Zhao Q., Zhang F., Dou K. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int. J. Clin. Pract. 2008, 62:1212-1218.
8. Suetsugu A., Nagaki M., Aoki H., Motohashi T., Kunisada T., Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem. Biophys. Res. Commun. 2006, 351:820-824.
9. Gatenby R.A., Gillies R.J. A microenvironmental model of carcinogenesis. Nat. Rev. Cancer. 2008, 8:56-61.
10. Costa F.F., Seftor E.A., Bischof J.M., Kirschmann D.A., Strizzi L., Arndt K., Bonaldo Mde F., Soares M.B., Hendrix M.J. Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics 2009, 1:387-398.
11. Yang Z., Klionsky D.J. An overview of the molecular mechanism of autophagy. Curr. Top. Microbiol. Immunol. 2009, 335:1-32.
12. Klionsky D.J., Emr S.D. Autophagy as a regulated pathway of cellular degradation. Science 2000, 290:1717-1721.
13. Levine B. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 2005, 120:159-162.
14. Eskelinen E.L. New insights into the mechanisms of macroautophagy in mammalian cells. Int. Rev. Cell Mol. Biol. 2008, 266:207-247.
15. Codogno P., Meijer A.J. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 2005, 12:1509-1518.
16. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
17. Johansen T., Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011, 7:279-296.
18. Ma S., Tang K.H., Chan Y.P., Lee T.K., Kwan P.S., Castilho A., Ng I., Man K., Wong N., To K.F., Zheng B.J., Lai P.B., Lo C.M., Chan K.W., Guan X.Y. MiR-130b promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell 2010, 7:694-707.
19. Izuishi K., Kato K., Ogura T., Kinoshita T., Esumi H. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res. 2000, 60:6201-6207.
20. Helmlinger G., Yuan F., Dellian M., Jain R.K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 1997, 3:177-182.
21. Cosse J.P., Michiels C. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med. Chem. 2008, 8:790-797.
22. Gong C., Song E., Codogno P., Mehrpour M. The roles of BECN1 and autophagy in cancer are context dependent. Autophagy 2012, 8:1853-1855.
23. Bampton E.T., Goemans C.G., Niranjan D., Mizushima N., Tolkovsky A.M. The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo/lysosomes. Autophagy 2005, 1:23-36.
24. Hanada T., Noda N.N., Satomi Y., Ichimura Y., Fujioka Y., Takao T., Inagaki F., Ohsumi Y. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J. Biol. Chem. 2007, 282:37298-37302.
25. Hanada T., Ohsumi Y. Structure-function relationship of Atg12, a ubiquitin-like modifier essential for autophagy. Autophagy 2005, 1:110-118.
26. Kim K.W., Mutter R.W., Cao C., Albert J.M., Freeman M., Hallahan D.E., Lu B. Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. J. Biol. Chem. 2006, 281:36883-36890.
27. Qu X., Yu J., Bhagat G., Furuya N., Hibshoosh H., Troxel A., Rosen J., Eskelinen E.L., Mizushima N., Ohsumi Y., Cattoretti G., Levine B. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 2003, 112:1809-1820.
28. Ahn C.H., Jeong E.G., Lee J.W., Kim M.S., Kim S.H., Kim S.S., Yoo N.J., Lee S.H. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS 2007, 115:1344-1349.
29. Azad M.B., Chen Y., Henson E.S., Cizeau J., McMillan-Ward E., Israels S.J., Gibson S.B. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 2008, 4:195-204.
30. Mazure N.M., Pouyssegur J. Hypoxia-induced autophagy: cell death or cell survival?. Curr. Opin. Cell Biol. 2010, 22:177-180.
31. Castano Z., Fillmore C.M., Kim C.F., McAllister S.S. The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells. Semin. Cancer Biol. 2012, 22:462-470.
32. Prados M.D., Levin V. Biology and treatment of malignant glioma. Semin. Oncol. 2000, 27:1-10.
33. Desjardins A., Rich J.N., Quinn J.A., Vredenburgh J., Gururangan S., Sathornsumetee S., Reardon D.A., Friedman A.H., Bigner D.D., Friedman H.S. Chemotherapy and novel therapeutic approaches in malignant glioma. Front Biosci. 2005, 10:2645-2668.
34. Kim E.H., Sohn S., Kwon H.J., Kim S.U., Kim M.J., Lee S.J., Choi K.S. Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Cancer Res. 2007, 67:6314-6324.
35. Abedin M.J., Wang D., McDonnell M.A., Lehmann U., Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 2007, 14:500-510.
36. Moore M.N. Autophagy as a second level protective process in conferring resistance to environmentally-induced oxidative stress. Autophagy 2008, 4:254-256.
37. Gozuacik D., Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 2004, 23:2891-2906.
38. Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751.
39. Creighton C.J., Li X., Landis M., Dixon J.M., Neumeister V.M., Sjolund A., Rimm D.L., Wong H., Rodriguez A., Herschkowitz J.I., Fan C., Zhang X., He X., Pavlick A., Gutierrez M.C., Renshaw L., Larionov A.A., Faratian D., Hilsenbeck S.G., Perou C.M., Lewis M.T., Rosen J.M., Chang J.C. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. USA 2009, 106:13820-13825.